The Role of Heat Shock Protein 70 in the Protective Effect of YC-1 on β-Amyloid-Induced Toxicity in Differentiated PC12 Cells

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tsai, Yung Chieh ^a,b,c   Lee, Yen Mei ^d   Lam, Kwok Keung ^b,e   Lin, Jui Fen ^d   Wang, Jhi Joung ^a   Yen, Mao Hsiung ^d   Cheng, Pao Yun ^f  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e Catholic Mercy Hospital Hsinchu   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; AMYLOID BETA PROTEIN[25-35]; CALPAIN 1; HEAT SHOCK PROTEIN 70; LIFICIGUAT; PROTEIN P25; QUERCETIN; SMALL INTERFERING RNA; TAU PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG TARGETING; GENETIC TRANSFECTION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PC12 CELL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; CALPAIN; CELL DIFFERENTIATION; GUANYLATE CYCLASE; HSP70 HEAT-SHOCK PROTEINS; INDAZOLES; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PC12 CELLS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 84880794115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069320     Document Type: Article

References (42)

1. Morgan C, Colombres M, Nuñez MT, Inestrosa NC, (2004) Structure and function of amyloid in Alzheimer's disease. Prog Neurobiol 74: 323-349.
2. Avila J, (2006) Tau phosphorylation and aggregation in Alzheimer's disease pathology. FEBS Lett 580: 2922-2927.
3. Di Rosa G, Odrijin T, Nixon RA, Arancio O, (2002) Calpain inhibitors: a treatment for Alzheimer's disease. J Mol Neurosci 19: 135-141.
4. Becker J, Craig EA, (1994) Heat-shock proteins as molecular chaperones. Eur J Biochem 219: 11-23.
5. Morimoto RI, Kline MP, Bimston DN, Cotto JJ, (1997) The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem 32: 17-29.
6. Brodsky JL, Chiosis G, (2006) Hsp70 molecular chaperones: emerging roles in human disease and identification of small molecule modulators. Curr Top Med Chem 6: 1215-1225.
7. Mayer MP, Bukau B, (2005) Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci 62: 670-684.
8. Perez N, Sugar J, Charya S, Johnson G, Merril C, et al. (1991) Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease. Brain Res Mol Brain Res 11: 249-254.
9. Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, et al. (2003) Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci U S A 100: 721-726.
10. Kirby BA, Merril CR, Ghanbari H, Wallace WC, (1994) Heat shock proteins protect against stress-related phosphorylation of tau in neuronal PC12 cells that have acquired thermotolerance. J Neurosci 14: 5687-5693.
11. Ko FN, Wu CC, Kuo SC, Lee FY, Teng CM, (1994) YC-1, a novel activator of platelet guanylate cyclase. Blood 84: 4226-4233.
12. Evgenov OV, Pacher P, Schmidt PM, Haskó G, Schmidt HH, et al. (2006) NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5: 755-768.
13. Tulis DA, (2004) Salutary properties of YC-1 in the cardiovascular and hematological systems. Curr Med Chem Cardiovasc Hematol Agents 2: 343-359.
14. Liu YN, Pan SL, Peng CY, Huang DY, Guh JH, et al. (2008) YC-1 induces heat shock protein 70 expression and prevents oxidized LDL-mediated apoptosis in vascular smooth muscle cells. Shock 30: 274-279.
15. Selkoe DJ, (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399: A23-A31.
16. Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS, (1995) The toxicity in vitro of beta-amyloid protein. Biochem J 311: 1-16.
17. Shearman MS, Ragan CI, Iversen LL, (1994) Inhibition of PC 12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A 91: 1470-1474.
18. Heo HJ, Yang HC, Cho HY, Hong B, Lim ST, et al. (2000) Inhibitory effect of Artemisia asiatica alkaloids on acetyl-cholinesterase activity from rat PC12 cells. Mol Cells 10: 253-262.
19. Cheng PY, Lee YM, Shih NL, Chen YC, Yen MH, (2006) Heme oxygenase-1 contributes to the cytoprotection of alpha-lipoic acid via activation of p44/42 mitogen-activated protein kinase in vascular smooth muscle cells. Free Radic Biol Med 40: 1313-1322.
20. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A, (2002) Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A 99: 6364-6369.
21. Busciglio J, Lorenzo A, Yeh J, Yankner BA, (1995) Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14: 879-888.
22. Greenberg SM, Qiu WQ, Selkoe DJ, Ben-Itzhak A, Kosik KS, (1995) Aminoterminal region of beta-amyloid precursor protein activates mitogenactivated protein kinase. Neurosci Lett 198: 52-56.
23. Rapoport M, Ferreira A, (2000) PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid inmature hippocampalneurons. J Neurochem 74: 125-133.
24. Takashima A, Honda T, Yasutake K, Michel G, Murayama O, et al. (1998) Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res 31: 317-323.
25. Zheng WH, Bastianetto S, Mennicken F, Ma W, Kar S, (2002) Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 115: 201-211.
26. Rank KB, Pauley AM, Bhattacharya K, Wang Z, Evans DB, et al. (2002) Direct interaction of soluble human recombinant Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II. FEBS Lett 514: 263-268.
27. Leschik J, Welzel A, Weissmann C, Eckert A, Brandt R, (2007) Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death. J Neurochem 101: 1303-1315.
28. Zhou XW, Li X, Bjorkdahl C, Sjogren MJ, Alafuzoff I, et al. (2006) Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains. Neurobiol Dis 22: 657-668.
29. Liu F, Grundke-Iqbal I, Iqbal K, Oda Y, Tomizawa K, et al. (2005) Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem 280: 37755-37762.
30. Saito K, Elce JS, Hamos JE, Nixon RA, (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 90: 2628-2632.
31. Tsuji T, Shimohama S, Kimura J, Shimizu K, (1998) m-Calpain (calcium- activated neutral proteinase) in Alzheimer's disease brains. Neurosci Lett 248: 109-112.
32. Chen M, Fernandez HL, (2005) Mu-calpain is functionally required for alpha-processing of Alzheimer's beta-amyloid precursor protein. Biochem Biophys Res Commun 330: 714-721.
33. Fifre A, Sponne I, Koziel V, Kriem B, Yen Potin FT, et al. (2006) Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid beta-peptide-induced neuronal apoptosis. Synergistic involvement of calpain and caspase-3. J Biol Chem 281: 229-240.
34. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, et al. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405: 360-364.
35. Park SY, Ferreira A, (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 25: 5365-5375.
36. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, et al. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402: 615-622.
37. Morimoto RI, Santoro MG, (1998) Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol 16: 833-838.
38. Wegele H, Müller L, Buchner J, (2004) Hsp70 and Hsp90-a relay team for protein folding. Rev Physiol Biochem Pharmacol 151: 1-44.
39. Frydman J, (2001) Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu Rev Biochem 70: 603-647.
40. Muchowski PJ, Wacker JL, (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6: 11-22.
41. Sherman MY, Goldberg AL, (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29: 15-32.
42. Evans CG, Wisén S, Gestwicki JE, (2006) Heat shock protein 70 and 90 inhibit early stages of amyloid β-(1-42) aggregation in vitro. J Biol Chem 281: 33182-33191.